Literature DB >> 16259733

AP-1 and colorectal cancer.

Reiko Ashida1, Kazunari Tominaga, Eiji Sasaki, Toshio Watanabe, Yasuhiro Fujiwara, Nobuhide Oshitani, Kazuhide Higuchi, Shokei Mitsuyama, Hiroshi Iwao, Tetsuo Arakawa.   

Abstract

Activator protein-1 (AP-1) is a transcription factor that consists of either a Jun-Jun homodimer or a Jun-Fos heterodimer. AP-1 regulates the expression of multiple genes essential for cell proliferation, differentiation and apoptosis. Numerous reports suggest that AP-1 plays an important role in various human diseases. Among them, the roles relating to human cancers have been strongly suggested for a long time. In human cancers, colorectal cancer is still a leading cause of morbidity and mortality in the world. Since there are some reports about the role of AP-1 in colorectal cancer response to a number of stimuli, such as cytokines and growth factors, and oncogenictransformation, therapeutic inhibition of AP-1 activity has attracted considerable interest. Here, we demonstrate the biological properties of AP-1 and its role in colorectal cancer, and discuss a possibility of an AP-1 inhibitor, an adenovirus dominant-negative mutant of c-Jun, as a therapeutic agent for gene therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259733     DOI: 10.1163/156856005774423935

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  65 in total

Review 1.  Gene therapy for colorectal cancer.

Authors:  Daniel H Palmer; Ming-Jen Chen; David J Kerr
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

2.  Transcriptional repression of p21((Waf1/Cip1/Sdi1)) gene by c-jun through Sp1 site.

Authors:  C H Wang; Y P Tsao; H J Chen; H L Chen; H W Wang; S L Chen
Journal:  Biochem Biophys Res Commun       Date:  2000-04-02       Impact factor: 3.575

Review 3.  Brain injury: prolonged induction of transcription factors.

Authors:  K R Pennypacker; C A Kassed; S Eidizadeh; J P O'Callaghan
Journal:  Acta Neurobiol Exp (Wars)       Date:  2000       Impact factor: 1.579

4.  Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein.

Authors:  F van Straaten; R Müller; T Curran; C Van Beveren; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  AP-1 blockade inhibits the growth of normal and malignant breast cells.

Authors:  J H Ludes-Meyers; Y Liu; D Muñoz-Medellin; S G Hilsenbeck; P H Brown
Journal:  Oncogene       Date:  2001-05-17       Impact factor: 9.867

6.  In vivo activation of mitogen-activated protein kinases in rat intestinal neoplasia.

Authors:  L L Licato; T O Keku; J I Wurzelmann; S C Murray; J T Woosley; R S Sandler; D A Brenner
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

7.  Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure.

Authors:  Stefan Frantz; Daniela Fraccarollo; Helga Wagner; Thomas M Behr; Philip Jung; Christiane E Angermann; Georg Ertl; Johann Bauersachs
Journal:  Cardiovasc Res       Date:  2003-03       Impact factor: 10.787

Review 8.  Gene therapy for colon cancer.

Authors:  R M Zwacka; M G Dunlop
Journal:  Hematol Oncol Clin North Am       Date:  1998-06       Impact factor: 3.722

9.  Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats.

Authors:  N Shimizu; M Yoshiyama; T Omura; A Hanatani; S Kim; K Takeuchi; H Iwao; J Yoshikawa
Journal:  Cardiovasc Res       Date:  1998-04       Impact factor: 10.787

Review 10.  Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4.

Authors:  Matthew R Young; Hsin-Sheng Yang; Nancy H Colburn
Journal:  Trends Mol Med       Date:  2003-01       Impact factor: 11.951

View more
  32 in total

1.  Effect-based assessment of persistent organic pollutant and pesticide dumpsite using mammalian CALUX reporter cell lines.

Authors:  B Pieterse; I J C Rijk; E Simon; B M A van Vugt-Lussenburg; B F H Fokke; M van der Wijk; H Besselink; R Weber; B van der Burg
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-29       Impact factor: 4.223

2.  Silencing of CDK2, but not CDK1, separates mitogenic from anti-apoptotic signaling, sensitizing p53 defective cells for synthetic lethality.

Authors:  Tatyana S Nekova; Susanne Kneitz; Hermann Einsele; Ralf Bargou; Gernot Stuhler
Journal:  Cell Cycle       Date:  2016-11-10       Impact factor: 4.534

3.  Engineering pre-SUMO4 as efficient substrate of SENP2.

Authors:  Yan Liu; Chris A Kieslich; Dimitrios Morikis; Jiayu Liao
Journal:  Protein Eng Des Sel       Date:  2014-04       Impact factor: 1.650

4.  The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt.

Authors:  Olorunseun O Ogunwobi; Ian L P Beales
Journal:  Int J Colorectal Dis       Date:  2006-08-16       Impact factor: 2.571

5.  Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo.

Authors:  Laura Patras; Bianca Sylvester; Lavinia Luput; Alina Sesarman; Emilia Licarete; Alina Porfire; Dana Muntean; Denise Minerva Drotar; Alexandra Doina Rusu; Andras-Laszlo Nagy; Cornel Catoi; Ioan Tomuta; Laurian Vlase; Manuela Banciu; Marcela Achim
Journal:  Cancer Biol Ther       Date:  2017-07-11       Impact factor: 4.742

6.  Activator protein-1 (AP-1): a bridge between life and death in lung epithelial (A549) cells under hypoxia.

Authors:  Seema Yadav; Namita Kalra; Lilly Ganju; Mrinalini Singh
Journal:  Mol Cell Biochem       Date:  2017-06-06       Impact factor: 3.396

Review 7.  Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications.

Authors:  Hui Xu; Lei Liu; Weilin Li; Duowu Zou; Jun Yu; Lifu Wang; Chi Chun Wong
Journal:  Oncogene       Date:  2020-12-15       Impact factor: 9.867

8.  Short hairpin RNA screen indicates that Klotho beta/FGF19 protein overcomes stasis in human colonic epithelial cells.

Authors:  Jinyong Kim; Ugur Eskiocak; Guido Stadler; Zhenjun Lou; Makoto Kuro-o; Jerry W Shay; Woodring E Wright
Journal:  J Biol Chem       Date:  2011-10-21       Impact factor: 5.157

9.  High expression of Foxp3, IL-23p19 and survivin mRNA in colorectal carcinoma.

Authors:  Noyko Stanilov; Lyuba Miteva; Nikolay Mintchev; Spaska Stanilova
Journal:  Int J Colorectal Dis       Date:  2008-09-30       Impact factor: 2.571

10.  HIG2 promotes colorectal cancer progression via hypoxia-dependent and independent pathways.

Authors:  Sun-Hee Kim; Dingzhi Wang; Yun-Yong Park; Hiroshi Katoh; Ofer Margalit; Michal Sheffer; Hong Wu; Vijaykumar R Holla; Ju-Seog Lee; Raymond N DuBois
Journal:  Cancer Lett       Date:  2013-08-02       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.